Paraneoplastic neuronal intermediate filament autoimmunity
Open Access
- 30 October 2018
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology
- Vol. 91 (18), e1677-e1689
- https://doi.org/10.1212/wnl.0000000000006435
Abstract
Objective To describe paraneoplastic neuronal intermediate filament (NIF) autoimmunity. Methods Archived patient and control serum and CSF specimens were evaluated by tissue-based indirect immunofluorescence assay (IFA). Autoantigens were identified by Western blot and mass spectrometry. NIF specificity was confirmed by dual tissue section staining and 5 recombinant NIF-specific HEK293 cell-based assays (CBAs, for α-internexin, neurofilament light [NfL], neurofilament medium, or neurofilament heavy chain, and peripherin). NIF–immunoglobulin Gs (IgGs) were correlated with neurologic syndromes and cancers. Results Among 65 patients, NIF-IgG-positive by IFA and CBAs, 33 were female (51%). Median symptom onset age was 62 years (range 18–88). Patients fell into 2 groups, defined by the presence of NfL-IgG (21 patients, who mostly had ≥4 NIF-IgGs detected) or its absence (44 patients, who mostly had ≤2 NIF-IgGs detected). Among NfL-IgG-positive patients, 19/21 had ≥1 subacute onset CNS disorders: cerebellar ataxia (11), encephalopathy (11), or myelopathy (2). Cancers were detected in 16 of 21 patients (77%): carcinomas of neuroendocrine lineage (10) being most common (small cell [5], Merkel cell [3], other neuroendocrine [2]). Two of 257 controls (0.8%, both with small cell carcinoma) were positive by both IFA and CBA. Five of 7 patients with immunotherapy data improved. By comparison, the 44 NfL-IgG-negative patients had findings of unclear significance: diverse nervous system disorders (p = 0.006), as well as limited (p = 0.003) and more diverse (p < 0.0001) cancer accompaniments. Conclusions NIF-IgG detection by IFA, with confirmatory CBA testing that yields a profile including NfL-IgG, defines a paraneoplastic CNS disorder (usually ataxia or encephalopathy) accompanying neuroendocrine lineage neoplasia.Keywords
This publication has 39 references indexed in Scilit:
- Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosisJournal of Neurology, Neurosurgery & Psychiatry, 2012
- NEFL mRNA Expression Level Is a Prognostic Factor for Early-Stage Breast Cancer PatientsPLOS ONE, 2012
- Peripherin-IgG association with neurologic and endocrine autoimmunityJournal of Autoimmunity, 2010
- Anti-α-Internexin Autoantibody from Neuropsychiatric Lupus Induce Cognitive Damage via Inhibiting Axonal Elongation and Promote Neuron ApoptosisPLOS ONE, 2010
- Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodiesThe Lancet Neurology, 2008
- Intermediate filaments: from cell architecture to nanomechanicsNature Reviews Molecular Cell Biology, 2007
- The polypeptide composition of moving and stationary neurofilaments in cultured sympathetic neuronsCell Motility, 2007
- Isolation of Intermediate FilamentsCurrent Protocols in Cell Biology, 2006
- Dynamics of neuronal intermediate filaments: A developmental perspectiveCell Motility, 1992
- A molecular dissection of the carboxyterminal tails of the major neurofilament subunits NF‐M and NF‐HJournal of Neuroscience Research, 1991